Publications for Joar Guterstam

Article

1 Guterstam J, Tavic C, Barosso M, Beck O. A multicomponent LC-MS/MS method for drugs of abuse testing using volumetric DBS and a clinical evaluation by comparison with urine. Journal of pharmaceutical and biomedical analysis 2024 243: 116075-

View record in PubMed®
2 Guterstam J, Heilig M. Nya svenska diagnoskoder för beroendetillstånd i remission. Lakartidningen 2024 121:

View record in PubMed®
3 Brynte C, Konstenius M, Khemiri L, Bäcker A, Guterstam J, Levin FR, Jayaram-Lindström N, Franck J. The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject Study. European addiction research 2024 30:1 1-13

View record in PubMed®
4 Månsson V, Pettersson E, Mittendorfer-Rutz E, Guterstam J, Berman AH, Jayaram-Lindström N, Molero Y. The risk and development of work disability among individuals with gambling disorder: a longitudinal case-cohort study in Sweden. Psychological medicine 2024 54:7 1391-1402

View record in PubMed®
5 Metrebian N, Carter B, Eide D, McDonald R, Neale J, Parkin S, Dascal T, Mackie C, Day E, Guterstam J, Horsburgh K, Kåberg M, Kelleher M, Smith J, Thiesen H, Strang J. A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS. BMC public health 2023 23:1 1608-

View record in PubMed®
6 Guterstam J. Spelberoende – en allvarlig biverkan av dopaminagonister. Lakartidningen 2022 119:

View record in PubMed®
7 Guterstam J, Jayaram-Lindstrom N, Berrebi J, Petrovic P, Ingvar M, Fransson P, Franck J. The Hypothesis of Subliminal Cue Reactivity in Addiction Revisited: An fMRI Study. EUROPEAN ADDICTION RESEARCH 2022 28:3 210-219

View record in PubMed®
8 Khemiri L, Brynte C, Konstenius M, Guterstam J, Rosendahl I, Franck J, Jayaram-Lindström N. Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychometric properties of the Swedish Barratt impulsiveness scale. BMC psychiatry 2021 21:1 458-

View record in PubMed®
9 Khemiri L, Steensland P, Guterstam J, de Manzano O, Franck J, Jayaram-Lindstrom N. Effects of the monoamine stabilizer (-)OSU6162 on cognitive function in alcohol dependence. PSYCHOPHARMACOLOGY 2020 237:1 69-82

View record in PubMed®
10 Ponten M, Fust J, Kosek E, Guterstam J, Jensen K. Naltrexone during pain conditioning: A double-blind placebo-controlled experimental trial. MOLECULAR PAIN 2020 16: 1744806920927625-

View record in PubMed®
11 Guterstam J. Välkommet med ny standard för kiral analys av amfetamin. Lakartidningen 2020 117:

View record in PubMed®
12 Guterstam J, Jayaram-Lindström N, Berrebi J, Petrovic P, Ingvar M, Fransson P, Franck J. Cue reactivity and opioid blockade in amphetamine dependence: A randomized, controlled fMRI study. Drug and alcohol dependence 2018 191: 91-97

View record in PubMed®
13 Jayaram-Lindström N, Guterstam J, Häggkvist J, Ericson M, Malmlöf T, Schilström B, Halldin C, Cervenka S, Saijo T, Nordström AL, Franck J. Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study. Translational psychiatry 2017 7:4 e1104-

View record in PubMed®
14 Walther L, de Bejczy A, Löf E, Hansson T, Andersson A, Guterstam J, Hammarberg A, Asanovska G, Franck J, Söderpalm B, Isaksson A. Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level. Alcoholism, clinical and experimental research 2015 39:11 2200-8

View record in PubMed®
15 Khemiri L, Steensland P, Guterstam J, Beck O, Carlsson A, Franck J, Jayaram-Lindström N. The effects of the monoamine stabilizer (-)-OSU6162 on craving in alcohol dependent individuals: A human laboratory study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2015 25:12 2240-51

View record in PubMed®
16 de Bejczy A, Löf E, Walther L, Guterstam J, Hammarberg A, Asanovska G, Franck J, Isaksson A, Söderpalm B. Varenicline for treatment of alcohol dependence: a randomized, placebo-controlled trial. Alcoholism, clinical and experimental research 2015 39:11 2189-99

View record in PubMed®
17 Konstenius M, Jayaram-Lindström N, Guterstam J, Beck O, Philips B, Franck J. Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction (Abingdon, England) 2014 109:3 440-9

View record in PubMed®
18 Guterstam J, Jayaram-Lindström N, Cervenka S, Frost JJ, Farde L, Halldin C, Franck J. Effects of amphetamine on the human brain opioid system--a positron emission tomography study. The international journal of neuropsychopharmacology 2013 16:4 763-9

View record in PubMed®
19 Khemiri L, Guterstam J, Franck J, Jayaram-Lindström N. Alcohol dependence associated with increased utilitarian moral judgment: a case control study. PloS one 2012 7:6 e39882-

View record in PubMed®
20 Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Loberg EM, Medhus S, Tanum L, Franck J. Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?. BMC PSYCHIATRY 2012 12: 221-

View record in PubMed®

Review

1 Johansson Capusan A, Guterstam J, Ginsberg Y, Borg Skoglund L. [The dark side of ADHD - comorbidity with substance use disorder and criminality - an overview]. Lakartidningen 2022 119:

View record in PubMed®
2 Bloniecki Kallio V, Guterstam J, Franck J. [Substitution therapy tested against amphetamine dependence]. Lakartidningen 2016 113:

View record in PubMed®

Editorial

1 Guterstam J. Toward a European Standard of Training in Addiction Medicine and Psychology. EUROPEAN ADDICTION RESEARCH 2024 30:3 138-139

View record in PubMed®